Psyched Wellness（PSYC.F）株式概要健康補助食品会社であるサイケッド・ウェルネス社は、米国でキノコ由来の製品や関連する消費者向けパッケージ商品を製造・販売している。 詳細PSYC.F ファンダメンタル分析スノーフレーク・スコア評価0/6将来の成長0/6過去の実績0/6財務の健全性6/6配当金0/6リスク分析過去5年間で収益は年間2.6%減少しました。 意味のある時価総額がありません ( $3M )収益が 100 万ドル未満 ( CA$628K )過去1年間で株主の希薄化は大幅に進んだ +1 さらなるリスクすべてのリスクチェックを見るPSYC.F Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUS$Current PriceUS$0.0085136.1% 割高 内在価値ディスカウントEst. Revenue$PastFuture-8m6m2016201920222025202620282031Revenue CA$5.8mEarnings CA$564.8kAdvancedSet Fair ValueView all narrativesPsyched Wellness Ltd. 競合他社CCA IndustriesSymbol: OTCPK:CAWWMarket cap: US$3.6mCyanotechSymbol: OTCPK:CYANMarket cap: US$3.8mTradewinds UniversalSymbol: OTCPK:TRWDMarket cap: US$2.3mSynergy CHCSymbol: NasdaqCM:SNYRMarket cap: US$3.7m価格と性能株価の高値、安値、推移の概要Psyched Wellness過去の株価現在の株価CA$0.008552週高値CA$0.02252週安値CA$0.0067ベータ0.541ヶ月の変化-23.42%3ヶ月変化-20.56%1年変化-33.59%3年間の変化-84.93%5年間の変化-96.41%IPOからの変化-95.75%最新ニュースお知らせ • Mar 12Psyched Wellness Ltd. announced that it expects to receive CAD 1.719307 million in funding from Gotham Green Partners, LLC and affiliates and or co-investors of Gotham GreenPsyched Wellness Ltd. announced that it has entered into a non-binding term sheet with returning investors Gotham Green Fund I, L.P. and Gotham Green Fund I (Q), L.P. pursuant to which the Company shall complete a non-brokered private placement and will issue 170,228,410 common shares and common share purchase warrants for aggregate gross proceeds of up to CAD 1,719,306.941 on March 11, 2026. The Offering will be led by Gotham Green, and it may include affiliates and/or co-investors of Gotham Green. The company will raise proceeds in two tranches of up to CAD 859,653.47 each, subject to closing conditions. The Offering will consist of issuances of Common Shares at a price of CAD 0.0101 per Common Share and Warrants at a price of CAD 0.005 per Warrant. Each Warrant will entitle the holder thereof to acquire one additional Common Share at a price of CAD 0.0051 per Additional Share at any time on or before the Warrant expiry date, set sixty (60) months following the applicable closing date. The Company has obtained approval from the Canadian Securities Exchange (the "CSE") to issue the Common Shares and Warrants at a price lower than CAD 0.05 as the Offering Price is above the volume weighted average trading price of the Common Shares on the CSE for the 20 trading day period ending March 10, 2026. The Offering will be offered for purchase and sale to investors in the United States on a private placement basis. The initial tranche is scheduled to close on or about March 18, 2026 (the "Tranche 1 Closing Date") for aggregate gross proceeds of CAD 859,653.47 (the "Initial Tranche"). Subject to the policies of the CSE, closing of the second and final tranche could be for up to CAD 859,653.47 ("Tranche 2"). The Investor Group has no obligation to fund Tranche 2, and may elect to complete Tranche 2 in whole or in part or not at all in the Investor Group's sole discretion. Additionally, the closing of Tranche 2 shall be subject to satisfactory completion of due diligence in the Investor Group's sole discretion. All securities issued under the Offering will be subject to a four month and one day hold period from the applicable closing date and applicable legends as required pursuant to the U.S. Securities Act. Closing of the Offering is subject to customary closing conditions, including the approval of the CSE.お知らせ • Nov 27Psyched Wellness Ltd. Launches CalmerPsyched Wellness Ltd. announced the launch of Calmer, a new product offering that delivers twice the potency of its product, Calm. The Company has also enhanced the flavour profile of Calm in both the 30 ml and 60 ml formats, reducing the mushroom taste while maintaining potency and consumer experience. The launch coincides with Psyched's Black Friday promotion, offering customers a 40% discount site-wide (excluding merch) through December 1, 2025.お知らせ • Apr 10AME Wellness Inc. Working with its Advisors, Zerkalo LLC Completes an Initial Pilot Run of New Dietary Supplement in Form of 4 oz ShotPsyched Wellness Ltd. announced that its US subsidiary, AME Wellness Inc., working with its advisors, Zerkalo LLC, have completed an initial pilot run of new dietary supplement in form of a 4 oz shot. The purpose of this pilot run is to beta test the shot with a select target group of consumers and gather feedback on the taste, the effect, and marketing data relating to the product. As part of this process, the Company will stress test its website, 3pl and shipping process to ensure that its fulfilment capabilities are in place in advance of the product launch.お知らせ • Mar 04Psyched Wellness Ltd., Annual General Meeting, May 15, 2025Psyched Wellness Ltd., Annual General Meeting, May 15, 2025.お知らせ • Nov 27Psyched Wellness Ltd. Announces Resignation of Harrison Aaron as DirectorPsyched Wellness Ltd. announced that Harrison Aaron, a nominee of Gotham Green Partners, LLC ("Gotham Green"), has resigned as a director of the Company effective November 22, 2024.お知らせ • Jun 22Psyched Wellness Ltd. Announces Board ChangesPsyched Wellness Ltd. announced that Amanda Galbraith has resigned as a director of the Company effective June 19, 2023. The Company also announced that Harrison Aaron has been appointed as director effective June 19, 2023. Harrison Aaron: Mr. Aaron is a Principal at Santa Monica based investment firm Gotham Green Partners, LLC ("Gotham Green") having joined the firm in early 2019. During his time at Gotham Green, in addition to helping lead the firm's broader investment efforts, he co-founded cannabis e-commerce retail and delivery business Amuse.com (currently serving Los Angeles, the Bay Area, and Sacramento), as well as co-founding Sandland Sleep (SandlandSleep.com), nationwide seller of highly-effective natural sleep aids, and is currently serving on the boards of both companies, as well as serving on the boards of VIOLA Brands and Engin Sciences. Prior to his time at Gotham Green, from 2013 to 2019, he covered the consumer sector as a senior analyst on the investment team at NYC-based JANA Partners, a multi-billion-dollar hedge fund investing in companies undergoing, or with the potential to undergo, value-unlocking changes. Mr. Aaron began his career on Goldman Sachs' Hedge Fund Strategies and Cross Asset Sales teams from 2009-2013, after graduating magna cum laude and Phi Beta Kappa from Colgate University, with high honors in Mathematical Economics.最新情報をもっと見るRecent updatesお知らせ • Mar 12Psyched Wellness Ltd. announced that it expects to receive CAD 1.719307 million in funding from Gotham Green Partners, LLC and affiliates and or co-investors of Gotham GreenPsyched Wellness Ltd. announced that it has entered into a non-binding term sheet with returning investors Gotham Green Fund I, L.P. and Gotham Green Fund I (Q), L.P. pursuant to which the Company shall complete a non-brokered private placement and will issue 170,228,410 common shares and common share purchase warrants for aggregate gross proceeds of up to CAD 1,719,306.941 on March 11, 2026. The Offering will be led by Gotham Green, and it may include affiliates and/or co-investors of Gotham Green. The company will raise proceeds in two tranches of up to CAD 859,653.47 each, subject to closing conditions. The Offering will consist of issuances of Common Shares at a price of CAD 0.0101 per Common Share and Warrants at a price of CAD 0.005 per Warrant. Each Warrant will entitle the holder thereof to acquire one additional Common Share at a price of CAD 0.0051 per Additional Share at any time on or before the Warrant expiry date, set sixty (60) months following the applicable closing date. The Company has obtained approval from the Canadian Securities Exchange (the "CSE") to issue the Common Shares and Warrants at a price lower than CAD 0.05 as the Offering Price is above the volume weighted average trading price of the Common Shares on the CSE for the 20 trading day period ending March 10, 2026. The Offering will be offered for purchase and sale to investors in the United States on a private placement basis. The initial tranche is scheduled to close on or about March 18, 2026 (the "Tranche 1 Closing Date") for aggregate gross proceeds of CAD 859,653.47 (the "Initial Tranche"). Subject to the policies of the CSE, closing of the second and final tranche could be for up to CAD 859,653.47 ("Tranche 2"). The Investor Group has no obligation to fund Tranche 2, and may elect to complete Tranche 2 in whole or in part or not at all in the Investor Group's sole discretion. Additionally, the closing of Tranche 2 shall be subject to satisfactory completion of due diligence in the Investor Group's sole discretion. All securities issued under the Offering will be subject to a four month and one day hold period from the applicable closing date and applicable legends as required pursuant to the U.S. Securities Act. Closing of the Offering is subject to customary closing conditions, including the approval of the CSE.お知らせ • Nov 27Psyched Wellness Ltd. Launches CalmerPsyched Wellness Ltd. announced the launch of Calmer, a new product offering that delivers twice the potency of its product, Calm. The Company has also enhanced the flavour profile of Calm in both the 30 ml and 60 ml formats, reducing the mushroom taste while maintaining potency and consumer experience. The launch coincides with Psyched's Black Friday promotion, offering customers a 40% discount site-wide (excluding merch) through December 1, 2025.お知らせ • Apr 10AME Wellness Inc. Working with its Advisors, Zerkalo LLC Completes an Initial Pilot Run of New Dietary Supplement in Form of 4 oz ShotPsyched Wellness Ltd. announced that its US subsidiary, AME Wellness Inc., working with its advisors, Zerkalo LLC, have completed an initial pilot run of new dietary supplement in form of a 4 oz shot. The purpose of this pilot run is to beta test the shot with a select target group of consumers and gather feedback on the taste, the effect, and marketing data relating to the product. As part of this process, the Company will stress test its website, 3pl and shipping process to ensure that its fulfilment capabilities are in place in advance of the product launch.お知らせ • Mar 04Psyched Wellness Ltd., Annual General Meeting, May 15, 2025Psyched Wellness Ltd., Annual General Meeting, May 15, 2025.お知らせ • Nov 27Psyched Wellness Ltd. Announces Resignation of Harrison Aaron as DirectorPsyched Wellness Ltd. announced that Harrison Aaron, a nominee of Gotham Green Partners, LLC ("Gotham Green"), has resigned as a director of the Company effective November 22, 2024.お知らせ • Jun 22Psyched Wellness Ltd. Announces Board ChangesPsyched Wellness Ltd. announced that Amanda Galbraith has resigned as a director of the Company effective June 19, 2023. The Company also announced that Harrison Aaron has been appointed as director effective June 19, 2023. Harrison Aaron: Mr. Aaron is a Principal at Santa Monica based investment firm Gotham Green Partners, LLC ("Gotham Green") having joined the firm in early 2019. During his time at Gotham Green, in addition to helping lead the firm's broader investment efforts, he co-founded cannabis e-commerce retail and delivery business Amuse.com (currently serving Los Angeles, the Bay Area, and Sacramento), as well as co-founding Sandland Sleep (SandlandSleep.com), nationwide seller of highly-effective natural sleep aids, and is currently serving on the boards of both companies, as well as serving on the boards of VIOLA Brands and Engin Sciences. Prior to his time at Gotham Green, from 2013 to 2019, he covered the consumer sector as a senior analyst on the investment team at NYC-based JANA Partners, a multi-billion-dollar hedge fund investing in companies undergoing, or with the potential to undergo, value-unlocking changes. Mr. Aaron began his career on Goldman Sachs' Hedge Fund Strategies and Cross Asset Sales teams from 2009-2013, after graduating magna cum laude and Phi Beta Kappa from Colgate University, with high honors in Mathematical Economics.New Risk • Jun 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: US$8.63m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (27% average weekly change). Earnings have declined by 47% per year over the past 5 years. Revenue is less than US$1m (CA$72k revenue, or US$54k). Market cap is less than US$10m (US$8.63m market cap).お知らせ • May 20Psyched Wellness Ltd., Annual General Meeting, Jul 11, 2023Psyched Wellness Ltd., Annual General Meeting, Jul 11, 2023.お知らせ • Feb 03Psyched Wellness Ltd. Adds New Bottle Size for Their Amanita Muscaria Extract CalmPsyched Wellness Ltd. announced that they will be launching a new larger bottle size for their proprietary Amanita Muscaria Extract (AME-1) product Calm, on February 28th 2023. The new size will provide customers with double the servings per bottle, in a 60ml package. Calm is the first legal Amanita Muscaria extract available for sale in the USA.お知らせ • Aug 01Psyched Wellness Ltd. announced that it has received CAD 4.05606 million in fundingOn July 31, 2020, Psyched Wellness Ltd. (OTCPK:DCNP.F) closed the transaction. The company issued 1,875,595 common shares for gross proceeds of CAD $187,559.5 in its final tranche.お知らせ • Jul 30Psyched Wellness Corp. acquired Duncan Park Holdings Corporation (OTCPK:DCNP.F) in a reverse merger transaction.Psyched Wellness Corp. acquired Duncan Park Holdings Corporation (OTCPK:DCNP.F) in a reverse merger transaction on May 5, 2020. Pursuant to the acquisition Duncan Park Holdings Corporation acquired all of the outstanding common shares of Psyched Wellness in exchange for common shares of the Duncan Park Holdings Corporation on a one for one basis. The shareholders of Psyched Wellness were issued an aggregate of 18 million common shares. Duncan Park Holdings Corporation became the sole shareholder of all of the outstanding securities of Psyched Wellness and will carry on Psyched's business. As part of the transaction, Duncan Park Holdings Corporation will seek shareholder approval at its next meeting of shareholders to approve a change to the Duncan Park Holdings Corporation name to Psyched Wellness Ltd. or such other name. As a result of the transaction, Jeffrey Stevens, will be the Director and Chief Executive Officer, Keith Li, will be the Chief Financial Officer and Corporate Secretary, David Shisel, will be the Chief Operating Officer, Michael Nederhoff, will be the Director (Chairman), Terry Booth, Nicholas Kadysh, and Chris Hazelton, will act as the Directors of the combined company. Psyched Wellness Corp. completed the acquisition of Duncan Park Holdings Corporation (OTCPK:DCNP.F) in a reverse merger transaction on May 5, 2020.株主還元PSYC.FUS Personal ProductsUS 市場7D-15.5%4.7%1.0%1Y-33.6%-16.7%28.7%株主還元を見る業界別リターン: PSYC.F過去 1 年間で-16.7 % の収益を上げたUS Personal Products業界を下回りました。リターン対市場: PSYC.Fは、過去 1 年間で28.7 % のリターンを上げたUS市場を下回りました。価格変動Is PSYC.F's price volatile compared to industry and market?PSYC.F volatilityPSYC.F Average Weekly Movement30.1%Personal Products Industry Average Movement7.8%Market Average Movement7.2%10% most volatile stocks in US Market16.4%10% least volatile stocks in US Market3.1%安定した株価: PSYC.Fの株価は、 US市場と比較して過去 3 か月間で変動しています。時間の経過による変動: PSYC.Fの weekly volatility ( 30% ) は過去 1 年間安定していますが、依然としてUSの株式の 75% よりも高くなっています。会社概要設立従業員CEO（最高経営責任者ウェブサイトn/an/aJeff Stevenspsyched-wellness.comPsyched Wellness Ltd.は健康補助食品会社で、キノコ由来の製品や関連する消費者向けパッケージ製品を米国で製造・販売している。同社は、ストレス緩和、リラクゼーション、安眠を促進するアマニタ・マスカリア由来の水性エキス、お茶、カプセルの製品ラインを提供している。同社は製品をオンラインで販売している。同社は以前はダンカンパーク・ホールディングス・コーポレーションとして知られていたが、2020年7月にサイケッド・ウェルネス社に社名を変更した。サイケッド・ウェルネス社はカナダのトロントに本社を置いている。もっと見るPsyched Wellness Ltd. 基礎のまとめPsyched Wellness の収益と売上を時価総額と比較するとどうか。PSYC.F 基礎統計学時価総額US$2.94m収益（TTM）-US$4.01m売上高(TTM)US$454.24k6.5xP/Sレシオ-0.7xPER（株価収益率PSYC.F は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計PSYC.F 損益計算書（TTM）収益CA$627.52k売上原価CA$469.54k売上総利益CA$157.98kその他の費用CA$5.69m収益-CA$5.54m直近の収益報告Feb 28, 2026次回決算日該当なし一株当たり利益（EPS）-0.014グロス・マージン25.18%純利益率-882.36%有利子負債／自己資本比率0%PSYC.F の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/23 19:21終値2026/05/21 00:00収益2026/02/28年間収益2025/11/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Psyched Wellness Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Mar 12Psyched Wellness Ltd. announced that it expects to receive CAD 1.719307 million in funding from Gotham Green Partners, LLC and affiliates and or co-investors of Gotham GreenPsyched Wellness Ltd. announced that it has entered into a non-binding term sheet with returning investors Gotham Green Fund I, L.P. and Gotham Green Fund I (Q), L.P. pursuant to which the Company shall complete a non-brokered private placement and will issue 170,228,410 common shares and common share purchase warrants for aggregate gross proceeds of up to CAD 1,719,306.941 on March 11, 2026. The Offering will be led by Gotham Green, and it may include affiliates and/or co-investors of Gotham Green. The company will raise proceeds in two tranches of up to CAD 859,653.47 each, subject to closing conditions. The Offering will consist of issuances of Common Shares at a price of CAD 0.0101 per Common Share and Warrants at a price of CAD 0.005 per Warrant. Each Warrant will entitle the holder thereof to acquire one additional Common Share at a price of CAD 0.0051 per Additional Share at any time on or before the Warrant expiry date, set sixty (60) months following the applicable closing date. The Company has obtained approval from the Canadian Securities Exchange (the "CSE") to issue the Common Shares and Warrants at a price lower than CAD 0.05 as the Offering Price is above the volume weighted average trading price of the Common Shares on the CSE for the 20 trading day period ending March 10, 2026. The Offering will be offered for purchase and sale to investors in the United States on a private placement basis. The initial tranche is scheduled to close on or about March 18, 2026 (the "Tranche 1 Closing Date") for aggregate gross proceeds of CAD 859,653.47 (the "Initial Tranche"). Subject to the policies of the CSE, closing of the second and final tranche could be for up to CAD 859,653.47 ("Tranche 2"). The Investor Group has no obligation to fund Tranche 2, and may elect to complete Tranche 2 in whole or in part or not at all in the Investor Group's sole discretion. Additionally, the closing of Tranche 2 shall be subject to satisfactory completion of due diligence in the Investor Group's sole discretion. All securities issued under the Offering will be subject to a four month and one day hold period from the applicable closing date and applicable legends as required pursuant to the U.S. Securities Act. Closing of the Offering is subject to customary closing conditions, including the approval of the CSE.
お知らせ • Nov 27Psyched Wellness Ltd. Launches CalmerPsyched Wellness Ltd. announced the launch of Calmer, a new product offering that delivers twice the potency of its product, Calm. The Company has also enhanced the flavour profile of Calm in both the 30 ml and 60 ml formats, reducing the mushroom taste while maintaining potency and consumer experience. The launch coincides with Psyched's Black Friday promotion, offering customers a 40% discount site-wide (excluding merch) through December 1, 2025.
お知らせ • Apr 10AME Wellness Inc. Working with its Advisors, Zerkalo LLC Completes an Initial Pilot Run of New Dietary Supplement in Form of 4 oz ShotPsyched Wellness Ltd. announced that its US subsidiary, AME Wellness Inc., working with its advisors, Zerkalo LLC, have completed an initial pilot run of new dietary supplement in form of a 4 oz shot. The purpose of this pilot run is to beta test the shot with a select target group of consumers and gather feedback on the taste, the effect, and marketing data relating to the product. As part of this process, the Company will stress test its website, 3pl and shipping process to ensure that its fulfilment capabilities are in place in advance of the product launch.
お知らせ • Mar 04Psyched Wellness Ltd., Annual General Meeting, May 15, 2025Psyched Wellness Ltd., Annual General Meeting, May 15, 2025.
お知らせ • Nov 27Psyched Wellness Ltd. Announces Resignation of Harrison Aaron as DirectorPsyched Wellness Ltd. announced that Harrison Aaron, a nominee of Gotham Green Partners, LLC ("Gotham Green"), has resigned as a director of the Company effective November 22, 2024.
お知らせ • Jun 22Psyched Wellness Ltd. Announces Board ChangesPsyched Wellness Ltd. announced that Amanda Galbraith has resigned as a director of the Company effective June 19, 2023. The Company also announced that Harrison Aaron has been appointed as director effective June 19, 2023. Harrison Aaron: Mr. Aaron is a Principal at Santa Monica based investment firm Gotham Green Partners, LLC ("Gotham Green") having joined the firm in early 2019. During his time at Gotham Green, in addition to helping lead the firm's broader investment efforts, he co-founded cannabis e-commerce retail and delivery business Amuse.com (currently serving Los Angeles, the Bay Area, and Sacramento), as well as co-founding Sandland Sleep (SandlandSleep.com), nationwide seller of highly-effective natural sleep aids, and is currently serving on the boards of both companies, as well as serving on the boards of VIOLA Brands and Engin Sciences. Prior to his time at Gotham Green, from 2013 to 2019, he covered the consumer sector as a senior analyst on the investment team at NYC-based JANA Partners, a multi-billion-dollar hedge fund investing in companies undergoing, or with the potential to undergo, value-unlocking changes. Mr. Aaron began his career on Goldman Sachs' Hedge Fund Strategies and Cross Asset Sales teams from 2009-2013, after graduating magna cum laude and Phi Beta Kappa from Colgate University, with high honors in Mathematical Economics.
お知らせ • Mar 12Psyched Wellness Ltd. announced that it expects to receive CAD 1.719307 million in funding from Gotham Green Partners, LLC and affiliates and or co-investors of Gotham GreenPsyched Wellness Ltd. announced that it has entered into a non-binding term sheet with returning investors Gotham Green Fund I, L.P. and Gotham Green Fund I (Q), L.P. pursuant to which the Company shall complete a non-brokered private placement and will issue 170,228,410 common shares and common share purchase warrants for aggregate gross proceeds of up to CAD 1,719,306.941 on March 11, 2026. The Offering will be led by Gotham Green, and it may include affiliates and/or co-investors of Gotham Green. The company will raise proceeds in two tranches of up to CAD 859,653.47 each, subject to closing conditions. The Offering will consist of issuances of Common Shares at a price of CAD 0.0101 per Common Share and Warrants at a price of CAD 0.005 per Warrant. Each Warrant will entitle the holder thereof to acquire one additional Common Share at a price of CAD 0.0051 per Additional Share at any time on or before the Warrant expiry date, set sixty (60) months following the applicable closing date. The Company has obtained approval from the Canadian Securities Exchange (the "CSE") to issue the Common Shares and Warrants at a price lower than CAD 0.05 as the Offering Price is above the volume weighted average trading price of the Common Shares on the CSE for the 20 trading day period ending March 10, 2026. The Offering will be offered for purchase and sale to investors in the United States on a private placement basis. The initial tranche is scheduled to close on or about March 18, 2026 (the "Tranche 1 Closing Date") for aggregate gross proceeds of CAD 859,653.47 (the "Initial Tranche"). Subject to the policies of the CSE, closing of the second and final tranche could be for up to CAD 859,653.47 ("Tranche 2"). The Investor Group has no obligation to fund Tranche 2, and may elect to complete Tranche 2 in whole or in part or not at all in the Investor Group's sole discretion. Additionally, the closing of Tranche 2 shall be subject to satisfactory completion of due diligence in the Investor Group's sole discretion. All securities issued under the Offering will be subject to a four month and one day hold period from the applicable closing date and applicable legends as required pursuant to the U.S. Securities Act. Closing of the Offering is subject to customary closing conditions, including the approval of the CSE.
お知らせ • Nov 27Psyched Wellness Ltd. Launches CalmerPsyched Wellness Ltd. announced the launch of Calmer, a new product offering that delivers twice the potency of its product, Calm. The Company has also enhanced the flavour profile of Calm in both the 30 ml and 60 ml formats, reducing the mushroom taste while maintaining potency and consumer experience. The launch coincides with Psyched's Black Friday promotion, offering customers a 40% discount site-wide (excluding merch) through December 1, 2025.
お知らせ • Apr 10AME Wellness Inc. Working with its Advisors, Zerkalo LLC Completes an Initial Pilot Run of New Dietary Supplement in Form of 4 oz ShotPsyched Wellness Ltd. announced that its US subsidiary, AME Wellness Inc., working with its advisors, Zerkalo LLC, have completed an initial pilot run of new dietary supplement in form of a 4 oz shot. The purpose of this pilot run is to beta test the shot with a select target group of consumers and gather feedback on the taste, the effect, and marketing data relating to the product. As part of this process, the Company will stress test its website, 3pl and shipping process to ensure that its fulfilment capabilities are in place in advance of the product launch.
お知らせ • Mar 04Psyched Wellness Ltd., Annual General Meeting, May 15, 2025Psyched Wellness Ltd., Annual General Meeting, May 15, 2025.
お知らせ • Nov 27Psyched Wellness Ltd. Announces Resignation of Harrison Aaron as DirectorPsyched Wellness Ltd. announced that Harrison Aaron, a nominee of Gotham Green Partners, LLC ("Gotham Green"), has resigned as a director of the Company effective November 22, 2024.
お知らせ • Jun 22Psyched Wellness Ltd. Announces Board ChangesPsyched Wellness Ltd. announced that Amanda Galbraith has resigned as a director of the Company effective June 19, 2023. The Company also announced that Harrison Aaron has been appointed as director effective June 19, 2023. Harrison Aaron: Mr. Aaron is a Principal at Santa Monica based investment firm Gotham Green Partners, LLC ("Gotham Green") having joined the firm in early 2019. During his time at Gotham Green, in addition to helping lead the firm's broader investment efforts, he co-founded cannabis e-commerce retail and delivery business Amuse.com (currently serving Los Angeles, the Bay Area, and Sacramento), as well as co-founding Sandland Sleep (SandlandSleep.com), nationwide seller of highly-effective natural sleep aids, and is currently serving on the boards of both companies, as well as serving on the boards of VIOLA Brands and Engin Sciences. Prior to his time at Gotham Green, from 2013 to 2019, he covered the consumer sector as a senior analyst on the investment team at NYC-based JANA Partners, a multi-billion-dollar hedge fund investing in companies undergoing, or with the potential to undergo, value-unlocking changes. Mr. Aaron began his career on Goldman Sachs' Hedge Fund Strategies and Cross Asset Sales teams from 2009-2013, after graduating magna cum laude and Phi Beta Kappa from Colgate University, with high honors in Mathematical Economics.
New Risk • Jun 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: US$8.63m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (27% average weekly change). Earnings have declined by 47% per year over the past 5 years. Revenue is less than US$1m (CA$72k revenue, or US$54k). Market cap is less than US$10m (US$8.63m market cap).
お知らせ • May 20Psyched Wellness Ltd., Annual General Meeting, Jul 11, 2023Psyched Wellness Ltd., Annual General Meeting, Jul 11, 2023.
お知らせ • Feb 03Psyched Wellness Ltd. Adds New Bottle Size for Their Amanita Muscaria Extract CalmPsyched Wellness Ltd. announced that they will be launching a new larger bottle size for their proprietary Amanita Muscaria Extract (AME-1) product Calm, on February 28th 2023. The new size will provide customers with double the servings per bottle, in a 60ml package. Calm is the first legal Amanita Muscaria extract available for sale in the USA.
お知らせ • Aug 01Psyched Wellness Ltd. announced that it has received CAD 4.05606 million in fundingOn July 31, 2020, Psyched Wellness Ltd. (OTCPK:DCNP.F) closed the transaction. The company issued 1,875,595 common shares for gross proceeds of CAD $187,559.5 in its final tranche.
お知らせ • Jul 30Psyched Wellness Corp. acquired Duncan Park Holdings Corporation (OTCPK:DCNP.F) in a reverse merger transaction.Psyched Wellness Corp. acquired Duncan Park Holdings Corporation (OTCPK:DCNP.F) in a reverse merger transaction on May 5, 2020. Pursuant to the acquisition Duncan Park Holdings Corporation acquired all of the outstanding common shares of Psyched Wellness in exchange for common shares of the Duncan Park Holdings Corporation on a one for one basis. The shareholders of Psyched Wellness were issued an aggregate of 18 million common shares. Duncan Park Holdings Corporation became the sole shareholder of all of the outstanding securities of Psyched Wellness and will carry on Psyched's business. As part of the transaction, Duncan Park Holdings Corporation will seek shareholder approval at its next meeting of shareholders to approve a change to the Duncan Park Holdings Corporation name to Psyched Wellness Ltd. or such other name. As a result of the transaction, Jeffrey Stevens, will be the Director and Chief Executive Officer, Keith Li, will be the Chief Financial Officer and Corporate Secretary, David Shisel, will be the Chief Operating Officer, Michael Nederhoff, will be the Director (Chairman), Terry Booth, Nicholas Kadysh, and Chris Hazelton, will act as the Directors of the combined company. Psyched Wellness Corp. completed the acquisition of Duncan Park Holdings Corporation (OTCPK:DCNP.F) in a reverse merger transaction on May 5, 2020.
